This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millon, L
Right arrow Articles by Michel-Briand, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millon, L
Right arrow Articles by Michel-Briand, Y

 Previous Article  |  Next Article 

J Clin Microbiol. 1994 April; 32(4): 1115-1118

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

L Millon, A Manteaux, G Reboux, C Drobacheff, M Monod, T Barale and Y Michel-Briand

Laboratorie de Bactériologie et Parasitologie, Faculté de Médecine, Hopital Jean Minjoz, Besançon, France.

ABSTRACT

Thirty human immunodeficiency virus-positive patients carrying Candida albicans in their oropharynx were treated with fluconazole and were monitored for 90 to 570 days. Fluconazole-resistant C. albicans (MIC, > 32 micrograms/ml) appeared only in seven patients and only after 90 days of treatment corresponding to a total dose of more than 10 g. Resistance was not associated with resistance to other azole derivatives. Susceptible and resistant strains from each patient had the same genotype (as defined by electrophoretic karyotype and restriction fragment length polymorphism). Thus, the resistant strains were selected by the antimycotic treatment from the susceptible strain present in each case.

J Clin Microbiol. 1994 April; 32(4): 1115-1118




This article has been cited by other articles:

  • Dabas, N., Schneider, S., Morschhauser, J. (2009). Mutational Analysis of the Candida albicans Ammonium Permease Mep2p Reveals Residues Required for Ammonium Transport and Signaling. Eukaryot Cell 8: 147-160 [Abstract] [Full Text]  
  • Schubert, S., Rogers, P. D., Morschhauser, J. (2008). Gain-of-Function Mutations in the Transcription Factor MRR1 Are Responsible for Overexpression of the MDR1 Efflux Pump in Fluconazole-Resistant Candida dubliniensis Strains. Antimicrob. Agents Chemother. 52: 4274-4280 [Abstract] [Full Text]  
  • Lermann, U., Morschhauser, J. (2008). Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology 154: 3281-3295 [Abstract] [Full Text]  
  • Dunkel, N., Liu, T. T., Barker, K. S., Homayouni, R., Morschhauser, J., Rogers, P. D. (2008). A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a Clinical Candida albicans Isolate. Eukaryot Cell 7: 1180-1190 [Abstract] [Full Text]  
  • Staib, P., Lermann, U., Bla -Warmuth, J., Degel, B., Wurzner, R., Monod, M., Schirmeister, T., Morschhauser, J. (2008). Tetracycline-Inducible Expression of Individual Secreted Aspartic Proteases in Candida albicans Allows Isoenzyme-Specific Inhibitor Screening. Antimicrob. Agents Chemother. 52: 146-156 [Abstract] [Full Text]  
  • Rautemaa, R., Richardson, M., Pfaller, M., Koukila-Kahkola, P., Perheentupa, J., Saxen, H. (2007). Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 60: 889-892 [Abstract] [Full Text]  
  • Dabas, N., Morschhauser, J. (2007). Control of Ammonium Permease Expression and Filamentous Growth by the GATA Transcription Factors GLN3 and GAT1 in Candida albicans. Eukaryot Cell 6: 875-888 [Abstract] [Full Text]  
  • Hiller, D., Stahl, S., Morschhauser, J. (2006). Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate.. Antimicrob. Agents Chemother. 50: 2300-2308 [Abstract] [Full Text]  
  • Hiller, D., Sanglard, D., Morschhauser, J. (2006). Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans.. Antimicrob. Agents Chemother. 50: 1365-1371 [Abstract] [Full Text]  
  • Park, Y.-N., Morschhauser, J. (2005). Tetracycline-Inducible Gene Expression and Gene Deletion in Candida albicans. Eukaryot Cell 4: 1328-1342 [Abstract] [Full Text]  
  • Lotz, H., Sohn, K., Brunner, H., Muhlschlegel, F. A., Rupp, S. (2004). RBR1, a Novel pH-Regulated Cell Wall Gene of Candida albicans, Is Repressed by RIM101 and Activated by NRG1. Eukaryot Cell 3: 776-784 [Abstract] [Full Text]  
  • Bennett, J. E., Izumikawa, K., Marr, K. A. (2004). Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis. Antimicrob. Agents Chemother. 48: 1773-1777 [Abstract] [Full Text]  
  • Bader, T., Bodendorfer, B., Schroppel, K., Morschhauser, J. (2003). Calcineurin Is Essential for Virulence in Candida albicans. Infect. Immun. 71: 5344-5354 [Abstract] [Full Text]  
  • Makarova, N. U., Pokrowsky, V. V., Kravchenko, A. V., Serebrovskaya, L. V., James, M. J., McNeil, M. M., Lasker, B. A., Warnock, D. W., Reiss, E. (2003). Persistence of Oropharyngeal Candida albicans Strains with Reduced Susceptibilities to Fluconazole among Human Immunodeficiency Virus-Seropositive Children and Adults in a Long-Term Care Facility. J. Clin. Microbiol. 41: 1833-1837 [Abstract] [Full Text]  
  • Samaranayake, Y.H., Samaranayake, L.P., Dassanayake, R.S., Yau, J.Y. Y., Tsang, W.K., Cheung, B.P. K., Yeung, K.W. S. (2003). `Genotypic shuffling' of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis. J Med Microbiol 52: 349-359 [Abstract] [Full Text]  
  • Barchiesi, F., Maracci, M., Radi, B., Arzeni, D., Baldassarri, I., Giacometti, A., Scalise, G. (2002). Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50: 999-1002 [Abstract] [Full Text]  
  • Martinez, M., Lopez-Ribot, J. L., Kirkpatrick, W. R., Bachmann, S. P., Perea, S., Ruesga, M. T., Patterson, T. F. (2002). Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 49: 515-524 [Abstract] [Full Text]  
  • Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., Morschhauser, J. (2002). Transcriptional Regulators Cph1p and Efg1p Mediate Activation of the Candida albicans Virulence Gene SAP5 during Infection. Infect. Immun. 70: 921-927 [Abstract] [Full Text]  
  • Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., Donowitz, L. G. (2001). Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants. NEJM 345: 1660-1666 [Abstract] [Full Text]  
  • Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhauser, J. (2001). MDR1-Mediated Drug Resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 45: 3416-3421 [Abstract] [Full Text]  
  • Strauß, A., Michel, S., Morschhäuser, J. (2001). Analysis of Phase-Specific Gene Expression at the Single-Cell Level in the White-Opaque Switching System of Candida albicans. J. Bacteriol. 183: 3761-3769 [Abstract] [Full Text]  
  • Staib, P., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhäuser, J. (2001). Isogenic Strain Construction and Gene Targeting in Candida dubliniensis. J. Bacteriol. 183: 2859-2865 [Abstract] [Full Text]  
  • Soll, D. R. (2000). The Ins and Outs of DNA Fingerprinting the Infectious Fungi. Clin. Microbiol. Rev. 13: 332-370 [Abstract] [Full Text]  
  • Pelletier, R., Peter, J., Antin, C., Gonzalez, C., Wood, L., Walsh, T. J. (2000). Emergence of Resistance of Candida albicans to Clotrimazole in Human Immunodeficiency Virus-Infected Children: In Vitro and Clinical Correlations. J. Clin. Microbiol. 38: 1563-1568 [Abstract] [Full Text]  
  • Wirsching, S., Michel, S., Köhler, G., Morschhäuser, J. (2000). Activation of the Multiple Drug Resistance Gene MDR1 in Fluconazole-Resistant, Clinical Candida albicans Strains Is Caused by Mutations in a trans-Regulatory Factor. J. Bacteriol. 182: 400-404 [Abstract] [Full Text]  
  • Müller, F.-M. C., Kasai, M., Francesconi, A., Brillante, B., Roden, M., Peter, J., Chanock, S. J., Walsh, T. J. (1999). Transmission of an Azole-Resistant Isogenic Strain of Candida albicans among Human Immunodeficiency Virus-Infected Family Members with Oropharyngeal Candidiasis. J. Clin. Microbiol. 37: 3405-3408 [Abstract] [Full Text]  
  • Perepnikhatka, V., Fischer, F. J., Niimi, M., Baker, R. A., Cannon, R. D., Wang, Y.-K., Sherman, F., Rustchenko, E. (1999). Specific Chromosome Alterations in Fluconazole-Resistant Mutants of Candida albicans. J. Bacteriol. 181: 4041-4049 [Abstract] [Full Text]  
  • Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., Morschhäuser, J. (1998). Multiple Molecular Mechanisms Contribute to a Stepwise Development of Fluconazole Resistance in Clinical Candida albicans Strains. Antimicrob. Agents Chemother. 42: 3065-3072 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Turner, T. M., Fothergill, A. W., McCarthy, D. I., Redding, S. W., Rinaldi, M. G., Patterson, T. F. (1998). Fluconazole Disk Diffusion Susceptibility Testing of Candida Species. J. Clin. Microbiol. 36: 3429-3432 [Abstract] [Full Text]  
  • Marr, K. A., Lyons, C. N., Rustad, T., Bowden, R. A., White, T. C. (1998). Rapid, Transient Fluconazole Resistance in Candida albicans Is Associated with Increased mRNA Levels of CDR. Antimicrob. Agents Chemother. 42: 2584-2589 [Abstract] [Full Text]  
  • Jessup, C. J., Pfaller, M. A., Messer, S. A., Zhang, J., Tumberland, M., Mbidde, E. K., Ghannoum, M. A. (1998). Fluconazole Susceptibility Testing of Cryptococcus neoformans: Comparison of Two Broth Microdilution Methods and Clinical Correlates among Isolates from Ugandan AIDS Patients. J. Clin. Microbiol. 36: 2874-2876 [Abstract] [Full Text]  
  • Metzgar, D., van Belkum, A., Field, D., Haubrich, R., Wills, C. (1998). Random Amplification of Polymorphic DNA and Microsatellite Genotyping of Pre- and Posttreatment Isolates of Candida spp. from Human Immunodeficiency Virus-Infected Patients on Different Fluconazole Regimens. J. Clin. Microbiol. 36: 2308-2313 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., McAtee, R. K., Revankar, S. G., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G., Patterson, T. F. (1998). Comparative Evaluation of National Committee for Clinical Laboratory Standards Broth Macrodilution and Agar Dilution Screening Methods for Testing Fluconazole Susceptibility of Cryptococcus neoformans. J. Clin. Microbiol. 36: 1330-1332 [Abstract] [Full Text]  
  • White, T. C., Marr, K. A., Bowden, R. A. (1998). Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance. Clin. Microbiol. Rev. 11: 382-402 [Abstract] [Full Text]  
  • Gleason, T. G., May, A. K., Caparelli, D., Farr, B. M., Sawyer, R. G. (1997). Emerging Evidence of Selection of Fluconazole-Tolerant Fungi in Surgical Intensive Care Units. Arch Surg 132: 1197-1202 [Abstract]  
  • Jenkinson, H. F. (1996). Ins and Outs of Antimicrobial Resistance: Era of the Drug Pumps. JDR 75: 736-742 [Abstract]  
  • Cannon, R.D., Holmes, A.R., Mason, A.B., Monk, B.C. (1995). Oral Candida: Clearance, Colonization, or Candidiasis?. JDR 74: 1152-1161 [Abstract]  
  • Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., Morschhauser, J. (2000). Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. USA 97: 6102-6107 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»